CTRI/2018/02/011948招募中4 期
A prospective, 16 week, phase IV study to evaluate safety, tolerability and effectiveness in patients with severe dementia of the Alzheimer�s type exposed to rivastigmine (Exelon)15cm2 transdermal patch
ovartis India Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Patients willing to participate in the study by providing written informed consent.
- •2)Patients diagnosed with severe dementia secondary to Alzheimerââ?¬•s disease (AD)
- •3)Patientââ?¬•s prescribed with rivastigmine 27mg -15 cm2 transdermal patch as per discretion of treating physician
排除标准
- •1)Contraindication as per PI
- •2)Patients simultaneously participating in other studies
研究者
相似试验
已完成
4 期
To evaluate the Immunogenicity and Safety of Inactivated Japanese encephalitis vaccineCTRI/2020/02/023128Bharat Biotech International Ltd500
进行中（未招募）
不适用
A 4-week trial evaluating the efficacy, safety, and tolerability of GRT6005, a new centrally acting analgesic, in subjects with moderate to severe pain due to osteoarthritis of the knee.EUCTR2010-022556-23-ATGrünenthal GmbH170
已完成
不适用
ong-term follow-up of children who participated at 9-12 months of age in clinical trial PsA-TT-007 in MaliMeningococcal serogroup AInfections and InfestationsISRCTN37623829PATH825
进行中（未招募）
1 期
Study to Evaluate the Efficacy and Safety of OZURDEX® in Treatment Naïve Patients with Diabetic Macular EdemaEUCTR2018-004785-33-ESAllergan Pharmaceuticals International Limited150
进行中（未招募）
1 期
Evaluation of the benefits of immediate versus conventional treatment with BIC / FTC / TAF in naive patients with type 1 HIV infectioHIV infectionEUCTR2019-004871-38-ESFUNDACION JIMENEZ DIAZ HEALTH RESEARCH INSTITUTE20